Metabolic Disorders

Part of the Medical Radiology book series (MEDRAD)


Epileptic seizures are a frequent symptom in metabolic disorders. However, it is neither seizure semiology nor EEG or MRI findings that guide the physician to the correct diagnosis. It is more important to consider the clinical syndrome, the age at presentation, and appropriate laboratory investigations.


Celiac Disease Mitochondrial Disorder Neuronal Ceroid Lipofuscinosis Chronic Progressive External Ophtalmoplegia Basal Ganglion Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Appignani BA, Kaye EM, Wolpert SM (1996) CT and MR appearance of the brain in two children with molybdenum cofactor deficiency. AJNR Am J Neuroradiol 17(2):317–320PubMedGoogle Scholar
  2. Autti T, Joensuu R, Aberg L (2007) Decreased T2 signal in the thalami may be a sign of lysosomal storage disease. Neuroradiology 49(7):571–578PubMedCrossRefGoogle Scholar
  3. Barkovich AJ, Good WV, Koch TK, Berg BO (1993) Mitochondrial disorders: analysis of their clinical and imaging characteristic. AJNR Am J Neuroradiol 14:1119–1137PubMedGoogle Scholar
  4. Barkovich AJ, Peck WW (1997) MR of Zellweger syndrome. AJNR Am J Neuroradiol 18(6):1163–1170Google Scholar
  5. Barkovich AJ (2007) An approach to MRI of metabolic disorders in children. J Neurorad 34:75–78CrossRefGoogle Scholar
  6. Barnerias C, Saudubray JM, Touati G et al (2010) Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis. Dev Med Child Neurol 52:e1–e9PubMedCrossRefGoogle Scholar
  7. Berkovic SF, Carpenter S, Evans A et al (1989) Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. Brain 112:1231–1260PubMedCrossRefGoogle Scholar
  8. Brismar J, Ozand PT (1994) CT and MR of the brain in disorders of the propionate and methylmalonate metabolism. AJNR Am J Neuroradiol 15(8):1459–1473 ReviewGoogle Scholar
  9. Brismar J, Ozand PT (1995) CT and MR of the brain in glutaric acidemia type I: a review of 59 published cases and a report of 5 new patients. AJNR Am J Neuroradiol 16(4):675–683PubMedGoogle Scholar
  10. Chu K, Kang DW, Kim DE et al (2002) Diffusion-weighted and gradient echo magnetic resonance findings of hemichorea-hemiballismus associated with diabetic hyperglycemia: a hyperviscosity syndrome? Arch Neurol 59:448–452PubMedCrossRefGoogle Scholar
  11. Davis RL, Holohan PD, Shrimpton AE et al (1999) Familial encephalopathy with neuroserpin inclusion bodies. Am J Pathol 155:1901–1913PubMedCrossRefGoogle Scholar
  12. de Koning TJ, Jaeken J, Pineda M et al (2000) Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency. Neuropediatrics 31(6):287–292PubMedCrossRefGoogle Scholar
  13. de Koning TJ, Klomp LW (2004) Serine-deficiency syndromes. Curr Opin Neurol 17(2):197–204PubMedCrossRefGoogle Scholar
  14. Desai S, Ganesan K, Hegde A (2008) Biotinidase deficiency: a reversible metabolic encephalopathy—neuroimaging and MR spectroscopic findings in a series of four patients. Pediatr Radiol 38:848–856PubMedCrossRefGoogle Scholar
  15. Engelsen BA, Tzoulis C, Karlsen B et al (2008) POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain 131:818–828PubMedCrossRefGoogle Scholar
  16. Engelbrecht V, Rassek M, Huismann J, Wendel U (1997) MR and proton MR spectroscopy of the brain in hyperhomocysteinemia caused by methylenetetrahydrofolate reductase deficiency. AJNR Am J Neuroradiol 18(3):536–539PubMedGoogle Scholar
  17. Finsterer J, Zarrouk Mahjoub S (2012) Epilepsy in mitochondrial disorders. Seizure 21:316–321PubMedCrossRefGoogle Scholar
  18. Gambardella A, Muglia M, Labate A et al (2001) Juvenile Huntington’s disease presenting as progressive myoclonic epilepsy. Neurology 57(4):708–711PubMedCrossRefGoogle Scholar
  19. Gobbi G (2005) Coeliac disease, epilepsy and cerebral calcifications. Brain Dev 27:189–200PubMedCrossRefGoogle Scholar
  20. Gordon N (2004) Succinic semialdehyde dehydrogenase deficiency (SSADH) (4-hydroxybutyric aciduria, gamma-hydroxybutyric aciduria). Eur J Paediatr Neurol 8(5):261–265PubMedCrossRefGoogle Scholar
  21. Gospe SM Jr (2010) Pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency: unique clinical symptoms and non-specific EEG characteristics. Dev Med Child Neurol 52(7):602–603PubMedCrossRefGoogle Scholar
  22. Haas R, Dietrich R (2004) Neuroimaging of mitochondrial disorders. Mitochondrion 4:471–490PubMedCrossRefGoogle Scholar
  23. Haeberle J, Shahbeck N, Ibrahim K et al (2012) Glutamine supplementation in a child with inherited GS deficiency improves the clinical status and partially corrects the peripheral and central amino acid imbalance. Orphanet J Rare Dis 7(1):48CrossRefGoogle Scholar
  24. Hakonen AH, Heiskanen S, Juvonen V et al (2005) Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 77(3):430–441 (Epub 2005 Jul 27)Google Scholar
  25. Head RA, Brown RM, Zolkipli Z et al (2005) Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: dihydrolipoamide acetyltransferase (E2) deficiency. Ann Neurol 58:234–241PubMedCrossRefGoogle Scholar
  26. Huisman TA, Thiel T, Steinmann B, Zeilinger G, Martin E (2002) Proton magnetic resonance spectroscopy of the brain of a neonate with nonketotic hyperglycinemia: in vivo-in vitro (ex vivo) correlation. Eur Radiol 12(4):858–861PubMedCrossRefGoogle Scholar
  27. Inglese M, Rovaris M, Bianchi S et al (2001) Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber’s hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 70(4):444–449PubMedCrossRefGoogle Scholar
  28. Ito S, Shirai W, Asahina M, Hattori T (2008) Clinical and brain MR imaging features focusing on the brain stem and cerebellum in patients with myoclonic epilepsy with ragged-red fibers due to mitochondrial A8344G mutation. Am J Neuroradiol AJNR 29(2):392–395Google Scholar
  29. Jan W, Zimmerman RA, Wang ZJ et al (2003) MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 45(6):393–399PubMedCrossRefGoogle Scholar
  30. Klepper J, Leiendecker B (2007) GLUT1 deficiency syndrome—2007 update. Dev Med Child Neurol 49(9):707–716PubMedCrossRefGoogle Scholar
  31. Kono K, Okano Y, Nakayama K et al (2005) Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter. Radiology 236(2):630–636PubMedCrossRefGoogle Scholar
  32. Kovacs GG, Höftberger R, Najtenyl K et al (2005) Neuropathology of white matter disease in Lebers hereditary optic neuropathy. Brain 128:35–41PubMedCrossRefGoogle Scholar
  33. Kraoua I, Sedel F, Caillaud C et al (2011) A French experience of type 3 Gaucher disease: phenotypic diversity and neurological outcome of 10 patients. Brain Dev 33(2):131–139PubMedCrossRefGoogle Scholar
  34. Lamirel C, Cassereau J, Cochereau I et al (2010) Papilloedema and MRI enhancement of the prechiasmal optic nerve at the acute stage of Leber hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 81(5):578–580PubMedCrossRefGoogle Scholar
  35. Lebre AS, Rio M, Faivre d’Arcier L et al (2011) A common pattern of brain MRI imaging in mitochondrial diseases with complex I deficiency. J Med Genet 48(1):16–23PubMedCrossRefGoogle Scholar
  36. Lee YM, Kang HC, Lee JS et al (2008) Mitochondrial respiratory chain defects: underlying etiology in various epileptic conditions. Epilepsia 49:685–690PubMedCrossRefGoogle Scholar
  37. Mascalchi M, Michelucci R, Cosottini M et al (2002) Brainstem involvement in Unverricht–Lundborg disease (EPM1): An MRI and (1)H MRS study. Neurology 58(11):1686–1689PubMedCrossRefGoogle Scholar
  38. Mills PB, Footitt EJ, Mills KA et al (2010) Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency). Brain 133(Pt 7):2148–2159PubMedCrossRefGoogle Scholar
  39. Muñoz E, Campdelacreu J, Ferrer I et al (2004) Severe cerebral white matter involvement in a case of dentatorubropallidoluysian atrophy studied at autopsy. Arch Neurol 61(6):946–949PubMedCrossRefGoogle Scholar
  40. Niehusmann P, Surges R, von Wrede RD, Elger CE, Wellmer J, Reimann J, Urbach H, Vielhaber S, Bien CG, Kunz WS (2010) Mitochondrial dysfunction due to Leber’s hereditary optic neuropathy as a cause of visual loss during assessment for epilepsy surgery. Epilepsy Behav 20(1):38−43Google Scholar
  41. Pearl PL, Gibson KM (2004) Clinical aspects of the disorders of GABA metabolism in children. Curr Opin Neurol 17(2):107–113PubMedCrossRefGoogle Scholar
  42. Pearl PL, Gibson KM, Acosta MT (2003a) Clinical spectrum of succine semialdehyde dehyfrogenase deficiency. Neurology 60:1413–1417PubMedCrossRefGoogle Scholar
  43. Pearl PL, Novotny EJ, Acosta MT et al (2003b) Succinic semialdehyde dehydrogenase deficiency in children and adults. Ann Neurol 54(Suppl 6):S73–S80PubMedCrossRefGoogle Scholar
  44. Pearl PL, Shukla L, Theodore WH et al (2011) Epilepsy in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism. Brain Dev 33:769–805CrossRefGoogle Scholar
  45. Prasad AN, Levin S, Rupar CA, Prasad C (2011a) Menkes disease and infantile epilepsy. Brain Dev 33:866–876PubMedCrossRefGoogle Scholar
  46. Prasad AN, Rupar CA, Prasard C (2011b) Methylene tetrahydrofolate reductase (MTHFR) deficiency and infantile epilepsy. Brain Dev 33:758–789PubMedCrossRefGoogle Scholar
  47. Press GA, Barshop BA, Haas RH et al (1989) Abnormalities of the brain in nonketotic hyperglycinemia: MR manifestations. AJNR Am J Neuroradiol 10(2):315–321Google Scholar
  48. Raghavendra S, Ashalatha R, Sanjee V et al (2007) Focal neuronal loss, reversible subcortical focal T2 hypointensity in seizures with a nonketotic hyperglycemic hyperosmolar state. Neuroradiology 49:299–305PubMedCrossRefGoogle Scholar
  49. Ramachandran N, Girard JM, Turnbull J, Minassian BA (2009) The autosomal recessively inherited progressive myoclonus epilepsies and their genes. Epilepsia 50(Suppl 5):29–36PubMedCrossRefGoogle Scholar
  50. Ribacoba R, Salas-Puig J, Gonzalez C, Astudillo A (2006) Characteristics of status epilepticus in MELAS. Analysis of four cases. Neurologia 21:1–11PubMedGoogle Scholar
  51. Sammaritano M, Andermann F, Helanson D et al (1985) The syndrome of epilepsy and bilateral occipital cortical calcifications. Epilepsia 26:530CrossRefGoogle Scholar
  52. Saneto RP, Friedman SD, Shaw DWW (2008) Neuroimaging of mitochondrial disease. Mitochondrion 8:296–413CrossRefGoogle Scholar
  53. Santavuori P, Vanhanen SL, Sainio K et al (1993) Infantile neuronal ceroid-lipofuscinosis (INCL): diagnostic criteria. J Inherit Metab Dis 16(2):227–229 (Review)Google Scholar
  54. Santorelli FM, Shanske S, Macaya A et al (1993) The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh’s syndrome. Ann Neurol 34:827–834PubMedCrossRefGoogle Scholar
  55. Saudubray JM, Sedel F, Walter JH (2006) Clinical approach to treatable inborn metabolic diseases: an introduction. J Inherit Metab Dis 29(2–3):261–274Google Scholar
  56. Sedel F, Gourfinkel-An I, Lyon-Caen O et al (2007) Epilepsy and inborn errors of metabolism in adults: a diagnostic approach. J Inherit Metab Dis 30(6):846–854PubMedCrossRefGoogle Scholar
  57. Seijo-Martínez M, Navarro C, Castro del Río M et al (2005) L-2-hydroxyglutaric aciduria: clinical, neuroimaging, and neuropathological findings. Arch Neurol 62(4):666–670PubMedCrossRefGoogle Scholar
  58. Sener RN (2003) Nonketotic hyperglycinemia: diffusion magnetic resonance imaging findings. J Comput Assist Tomogr 27(4):538–540Google Scholar
  59. Sévin M, Lesca G, Baumann N et al (2007) The adult form of Niemann–Pick disease type C. Brain 130(Pt 1):120–133PubMedGoogle Scholar
  60. Shahwan A, Farrell M, Delanty N (2005) Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol 4(4):239–248PubMedCrossRefGoogle Scholar
  61. Soares-Fernandes JP, Teixeira-Gomes R, Cruz R et al (2008) Neonatal pyruvate dehydrogenase deficiency due to a R302H mutation in the PDHA1 gene: MRI findings. Pediatr Radiol 38:559–562Google Scholar
  62. Stöckler S, Holzbach U, Hanefeld F et al (1994) Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res 36(3):409–413PubMedCrossRefGoogle Scholar
  63. Stöckler-Ipsiroglu S, Plecko B (2009) Metabolic epilepsies: approaches to a diagnostic challenge. Can J Neurol Sci 36(Suppl 2):S67–S72PubMedGoogle Scholar
  64. Taly AB, Nagaraja D, Das S et al (1987) Sturge–Weber–Dimitri disease without facial nevus. Neurology 37:1063–1064PubMedCrossRefGoogle Scholar
  65. Thomas B, Al Dossary N, Widjaja E (2010) MRI of childhood epilepsy due to inborn errors of metabolism. AJR Am J Roentgenol 194(5):W367–W374PubMedCrossRefGoogle Scholar
  66. Tzoulis C, Engelsen BA, Telstad W et al (2006) The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129(Pt 7):1685–1692PubMedCrossRefGoogle Scholar
  67. Van der Knaap M, Valk J (2005) GM2 gangliosidosis. In: Magnetic resonance of myelin and myelination disorders, 3rd edn. Springer, Berlin, Heidelberg, New York, pp 103–111Google Scholar
  68. Vanhanen SL, Raininko R, Autti T, Santavuori P (1995) MRI evaluation of the brain in infantile neuronal ceroid-lipofuscinosis. Part 2: MRI findings in 21 patients. J Child Neurol 10(6):444–450PubMedCrossRefGoogle Scholar
  69. Vijayakumar K, Gunny R, Grunewald S et al (2011) Clinical neuroimaging features and outcome in molybdenum cofactor deficiency. Pediatr Neurol 45(4):246–252PubMedCrossRefGoogle Scholar
  70. Villanueva V, Alvarez-Linera J, Gómez-Garre P et al (2006) MRI volumetry and proton MR spectroscopy of the brain in Lafora disease. Epilepsia 47(4):788–792PubMedCrossRefGoogle Scholar
  71. Walker-Smith JA, Guendalini S, Schmitz J et al (1990) Revised criteria for diagnosis of coeliac disease. Arch Dis Child 65:909–911CrossRefGoogle Scholar
  72. Wang CP, Hsieh PF, Chen CC et al (2005) Hyperglycemia with occipital seizures: images and visual evoked potentials. Epilepsia 46:1140–1144PubMedCrossRefGoogle Scholar
  73. Weller S, Rosewich H, Gärtner J (2008) Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients. J Inherit Metabol Dis 31:270–280CrossRefGoogle Scholar
  74. Whaley NR, Fukoja S, Wszolek ZK (2011) Autosomal dominant cerebellar ataxia type I: a review of the phenotypic and genotypic characteristics. Orphanet J Rare Dis 6:33PubMedCrossRefGoogle Scholar
  75. Wolf B, Grier RE, Allen RJ et al (1983) Biotinidase deficiency: the enzyme defect in late-onset multiple carboxylase deficiency. Clin Chem Acta 131:273–281CrossRefGoogle Scholar
  76. Wolf B, Heard GS, Weissbecker KA et al (1985) Biotinidase deficiency: initial clinical features and rapid diagnosis. Ann Neurol 18(5):614–617PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Department of NeuroradiologyUniversity Hospital FreiburgFreiburgGermany
  2. 2.Department of NeurologyUniversity of BonnBonnGermany

Personalised recommendations